Multiplex Assay Kit for Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD178; CD95L; CD95-L; FASLG; FASLG; APT1LG1; APT1-LG1; TNFSF6; Fas Antigen Ligand; TNF Superfamily Member 6; Tumor Necrosis Factor(ligand)Superfamily,Member 6

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-105 102
EDTA plasma(n=5) 86-93 90
heparin plasma(n=5) 89-101 96
sodium citrate plasma(n=5) 83-103 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-102% 91-103% 78-101% 87-96%
EDTA plasma(n=5) 96-104% 89-102% 88-102% 88-97%
heparin plasma(n=5) 98-105% 87-105% 95-102% 99-105%
sodium citrate plasma(n=5) 78-96% 80-98% 78-95% 96-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FASL) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS Pathogens Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia PubMed: PMC3585175
Tumor Biology The diplotype Fas? 1377A/? 670G as a genetic marker to predict a lower risk of breast cancer in Chinese women Springer:Source
IOS Press Content Library An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's … articles:journal-of-alzheimers-disease
博士论文 INSTITUTO DE CIENCIAS BÁSICAS Y PRECLÍNICAS “VICTORIA DE GIRÓN” DEPARTAMENTO DE HISTOLOGÍA
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA031Mu02 Recombinant Factor Related Apoptosis Ligand (FASL) Positive Control; Immunogen; SDS-PAGE; WB.
EPA031Mu62 Eukaryotic Factor Related Apoptosis Ligand (FASL) Positive Control; Immunogen; SDS-PAGE; WB.
APA031Mu61 Active Factor Related Apoptosis Ligand (FASL) Cell culture; Activity Assays.
EPA031Mu61 Eukaryotic Factor Related Apoptosis Ligand (FASL) Positive Control; Immunogen; SDS-PAGE; WB.
RPA031Mu01 Recombinant Factor Related Apoptosis Ligand (FASL) Positive Control; Immunogen; SDS-PAGE; WB.
PAA031Mu02 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL) WB; IHC; ICC; IP.
PAA031Mu01 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL) WB; IHC; ICC; IP.
SEA031Mu ELISA Kit for Factor Related Apoptosis Ligand (FASL) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA031Mu CLIA Kit for Factor Related Apoptosis Ligand (FASL) Chemiluminescent immunoassay for Antigen Detection.
LMA031Mu Multiplex Assay Kit for Factor Related Apoptosis Ligand (FASL) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA031Mu01 ELISA Kit DIY Materials for Factor Related Apoptosis Ligand (FASL) Main materials for "Do It (ELISA Kit) Yourself".